Gonadotropin-releasing hormone (GnRH) agonists have been used in the management of different conditions including prostate cancer, precocious puberty, uterine bleeding due to endometriosis, as a transgender medicine, and fibroid treatment among others. The gene discussed is GNRH1; the disease is prostate cancer.